Windlas Biotech Limited (WINDLAS)
₹1,049
INR+17.40(+1.69%)
As of December 26, 2024 9:59:00 AMAbout Windlas Biotech Limited
Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. The company offers CDMO solutions, including product development, licensing, and commercial manufacturing of complex drugs and dosage forms. It also produces nutraceutical supplement products. In addition, the company manufactures tablets, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprising fixed dosage combinations, fixed dosage plus modified release combinations, customized generics, chewable or dispersible, and plain oral solids. Windlas Biotech Limited was incorporated in 2001 and is based in Gurugram, India.
RevenueLast 12 months
NA
+NA YoY
Total revenue generated from all business operations over the last 12 months
EBITDALast 12 months
NA
Earnings Before Interest, Taxes, Depreciation, and Amortization - a measure of company's operating performance
Price to Sales RatioTTM
3.26
Compares a company's stock price to its revenues. Lower ratio might indicate an undervalued stock
Operating MarginLast 12 months
8.38
+11.700000000000001% quarterly YoY
Operating income as a percentage of revenue, indicating operational efficiency
Market Cap
2158.39 CrINR
Total market value of the company's outstanding shares
Employees
1154
Total number of full-time employees worldwide
CEO
Ms. Komal Gupta
Chief Executive Officer of the company